Delian Capital

In 2011 was created Delian Capital, which is appeared as VC. The main department of described VC is located in the Beijing. The venture was found in Asia in China.

The fund has specific favorite in a number of founders of portfolio startups. In case when startup counts 3 or 5+ of the founder, the chance for it to get the investment is meager. Among the various public portfolio startups of the fund, we may underline HiFiBiO, MicuRx Pharmaceuticals, Panorama Medicine Besides, a startup needs to be aged 4-5 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. We can highlight the next thriving fund investment areas, such as Energy, Biopharma.

The top activity for fund was in 2019. The common things for fund are deals in the range of 10 - 50 millions dollars. The real fund results show that this VC is 22 percentage points more often commits exit comparing to other companies. The fund is generally included in 2-6 deals every year.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Delian Capital, startups are often financed by ZhenFund, Nest.Bio Ventures, Morningside Group. The meaningful sponsors for the fund in investment in the same round are ZhenFund, Wooshin Venture Investment Corp., WI Harper Group. In the next rounds fund is usually obtained by Weihe Investment, Jinpengjia Holdings, Guangzhou Yihe Investment.

Notable deals

Review

• No reviews are submitted yet.